Money

Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise

Pulse Reporter
Pulse Reporter
Novo Nordisk inventory surges 7% after Ozempic maker’s newest weight-loss drug exhibits promise




The brand new remedy targets intestine hormone GLP-1 but additionally mimics amylin, a hormone launched by the pancreas that suppresses starvation. Learn Extra

You Might Also Like

Microsoft faces broad antitrust investigation from U.S. FTC

Trump drops govt order stripping a legislation agency of its authorities contracts after he says it pledged $40 million in professional bono authorized companies to his administration’s causes

BlackRock fall 5% on blended earnings — why we would look to purchase Wednesday

Iranians are fleeing the capital as lengthy traces type at gasoline stations whereas Israeli assaults may worsen an power disaster

Decide will order Kilmar Abrego Garcia’s pre-trial launch however ICE plans to detain him

Share This Article
Previous Article DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee DeepSeek R1’s daring wager on reinforcement studying: The way it outpaced OpenAI at 3% of the fee
Next Article IHG Rewards Traveler Credit score Card assessment: Full particulars IHG Rewards Traveler Credit score Card assessment: Full particulars
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More News